c ebpβ-lip drug The C/EBPβ LIP isoform rescues loss of C/EBPβ function in the mouse C/EBP beta Antibody | Cell
C EBP beta Antibody Cell Signaling Technology C EBP sustains the oncogenic program of AML cells by cooperating with MYB and co activator p300 in a transcriptional module Experimental Hematology Frontiers Evidence that C EBP LAP Increases Fat Metabolism and Protects Against Diet Induced Obesity in Response to mTOR Inhibition C EBP: The structure, regulation, and its roles in inflammation related diseases ScienceDirect Increasing intratumor C EBP LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer Journal of Experimental & Clinical Cancer Research Springer Nature Link
Pay in 4 interest-free payments of $6.90 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



